Rare Diseases: The Unseen Health Crisis | Postpartum Doula Los Angeles

Rare diseases, affecting approximately 3.5% of the global population, or around 263 million people worldwide, pose significant challenges in diagnosis and treatment due to their low prevalence and limited research. The rarity of these conditions often results in delayed or incorrect diagnoses, with patients sometimes waiting years to receive an accurate diagnosis. According to the National Institutes of Health (NIH), there are over 7,000 known rare diseases, with new ones being discovered regularly. The Orphan Drug Act of 1983 has been instrumental in incentivizing the development of treatments for rare diseases, with over 800 orphan drugs approved by the FDA since its enactment. Despite these efforts, significant disparities in access to care and treatment options persist, particularly in low-income and middle-income countries. As research continues to uncover the genetic and molecular underpinnings of rare diseases, there is growing hope for the development of more effective treatments and potentially even cures for these debilitating conditions.